2/17/23 17:11 | 2/16/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 33 | 0.3300 | 0 | 100 | 3 | 3,335 | D | | | | | | | | | | | | | | |
2/17/23 17:11 | 2/16/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -108 | 1.08 | 0 | -100 | -3 | 3,335 | D | | | | | | | | | | | | | | |
1/19/23 16:12 | 1/17/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 51 | 0.5100 | 0 | 100 | 3 | 3,373 | D | | | | | | | | | | | | | | |
1/19/23 16:12 | 1/17/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -128 | 1.28 | 0 | -100 | -3 | 3,373 | D | | | | | | | | | | | | | | |
12/20/22 16:07 | 12/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 49 | 0.5100 | 0 | 96 | 5 | 1,898 | D | | | | | | | | | | | | | | |
12/20/22 16:07 | 12/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -137 | 1.43 | 0 | -96 | -5 | 1,898 | D | | | | | | | | | | | | | | |
10/14/22 16:15 | 10/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 51 | 0.5100 | 0 | 100 | 6 | 1,898 | D | | | | | | | | | | | | | | |
10/14/22 16:15 | 10/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -166 | 1.66 | 0 | -100 | -5 | 1,898 | D | | | | | | | | | | | | | | |
7/15/22 16:03 | 7/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 50 | 0.3300 | 0 | 150 | 9 | 1,898 | D | | | | | | | | | | | | | | |
7/15/22 16:03 | 7/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -408 | 2.72 | 0 | -150 | -7 | 1,898 | D | | | | | | | | | | | | | | |
5/13/22 16:02 | 5/13/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 41 | 0.3300 | 0 | 125 | 7 | 1,898 | D | | | | | | | | | | | | | | |
5/13/22 16:02 | 5/13/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -240 | 1.92 | 0 | -125 | -6 | 1,898 | D | | | | | | | | | | | | | | |